Journal Home
Search for

Volume 123, Issue 1, Pages 187-194 (January 2009)


View previous. 45 of 73 View next.

Allergenicity and antigenicity of fenugreek (Trigonella foenum-graecum) proteins in foods

Christiane Kruse Fæste, PhDaCorresponding Author Informationemail address, Ellen Namork, PhDb, Helene Lindvik, MMScc

Received 1 April 2008; received in revised form 20 August 2008; accepted 4 September 2008. published online 20 October 2008.

Background

Fenugreek is an ingredient in Indian-style spiced foods. Reports of adverse reactions reflect a trend toward a more international cuisine. Fenugreek allergy has not been systematically investigated so far.

Objective

Study the allergenicity and antigenicity of fenugreek proteins using patient sera and a newly developed polyclonal antifenugreek antibody.

Methods

Allergenic fenugreek proteins were identified by immunoblotting, using sera from 29 patients with specific IgE to peanut and other legumes. In addition, 2 patients were evaluated by skin prick test and open food challenge with native fenugreek powder. Spiced and flavored food products were analyzed for fenugreek by semiquantitative IgE and IgG immunoblotting.

Results

High levels of specific IgE to both peanut and fenugreek were seen in most sera. Fenugreek sensitization is believed to be a consequence of cross-reactivity in patients with peanut allergy. Primary fenugreek allergy was suspected in only 1 case. The fenugreek dose eliciting objective symptoms was about 2 mg in the open food challenge. Major fenugreek allergens were identified at 50, 52, and 74 kd and peanut proteins at 22, 36, and 40 kd. A specific polyclonal antifenugreek antibody was found suitable for food analysis. In a food survey, about 1/3 of the fenugreek-containing products were labeled correctly.

Conclusion

Fenugreek seed powder, an ingredient in spiced foods, contains several potential allergens. There is evidence for a high rate of cross-reactivity to peanut.

a National Veterinary Institute, Rikshospitalet University Hospital, Oslo, Norway

b Norwegian Institute of Public Health, Rikshospitalet University Hospital, Oslo, Norway

c Voksentoppen Children's Center for Asthma and Allergy, Rikshospitalet University Hospital, Oslo, Norway

Corresponding Author InformationReprint requests: Christiane Kruse Fæste, PhD, National Veterinary Institute, PO Box 750, Sentrum, N-0106 Oslo, Norway.

 Supported by the Norwegian Research Council.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01673-4

doi:10.1016/j.jaci.2008.09.012


View previous. 45 of 73 View next.